Pfizer (NYSE: PFE)
Pfizer Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Pfizer Company Info
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
News & Analysis
Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says
Pfizer presents a good buying opportunity, but not because of potential earnings.
Where Will Pfizer (PFE) Be in 5 Years?
The big drugmaker should be even bigger over the next five years despite facing a patent cliff.
Congressional Stock Trading: Who Trades and Makes the Most
Members of Congress have beaten the market in recent years but their trades have come under growing scrutiny
The Smartest Dividend Stocks to Buy With $1,000 Right Now
You'll often find the fattest dividend yields among stocks that have tumbled for some reason.
Investing in Cancer Stocks
Learn about some of the leading cancer stocks in the U.S stock market this year.
2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?
5 High-Yield Stock Picks to Add to Your Dividend Portfolio
It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth.
Valuation
Podcast Episodes
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
A look at stock market news.
Why Is a Coronavirus Vaccine Bad News for Some Stocks?
Investors knew that a vaccine was coming, so why did the market react the way it did?
Why Coronavirus Vaccine News Is Great for Bank Stocks and REITs
Some of our favorite banks and real estate stocks are having their best rallies in years.
2 Reasons Pfizer Is on Our Minds Today
First, it raised some spinoff speculation. Second, it's in an intriguing tussle with J&J that could affect the biosimilars market for everyone.
Earnings Transcripts
Pfizer (PFE) Q4 2024 Earnings Call Transcript
PFE earnings call for the period ending December 31, 2024.
Pfizer (PFE) Q3 2024 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2024.
Pfizer (PFE) Q2 2024 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2024.
Pfizer (PFE) Q1 2024 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.